Canada markets closed

FSD PHARMA B (0K9.F)

Frankfurt - Frankfurt Delayed Price. Currency in EUR
Add to watchlist
0.2900+0.0165 (+6.03%)
At close: 08:16AM CEST
Show:
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
2023-12-31
2022-12-31
2021-12-31
2020-12-31
2019-12-31
Total Revenue
0
0
0
0
0
-
Cost of Revenue
-
-
-
-
-
2,039
Gross Profit
-
-
-
-
-
-1,843
Operating Expenses
Research Development
5,068
3,859
6,911
6,328
7,833
-
Selling General and Administrative
17,333
13,205
15,981
23,370
18,110
-
Total Operating Expenses
26,889
19,570
27,430
33,744
30,601
-
Operating Income or Loss
-26,889
-19,570
-27,430
-33,744
-30,601
-
Interest Expense
77.892
0.299
48.822
69.404
235.581
-
Total Other Income/Expenses Net
181.927
553.462
407.036
-126.184
2,381
-
Income Before Tax
-26,718
-18,231
-26,704
-33,938
-28,452
-
Income from Continuing Operations
-26,718
-18,231
-26,704
-33,938
-28,452
-
Net Income
-23,806
-17,902
-23,607
-35,285
-31,800
-
Net Income available to common shareholders
-23,806
-17,902
-23,607
-35,285
-31,800
-
Basic EPS
-0.58
-0.46
-0.61
-1.01
-2.64
-
Diluted EPS
-0.58
-0.46
-0.61
-1.01
-2.64
-
Basic Average Shares
39,313
39,589
38,732
34,945
12,044
-
Diluted Average Shares
39,313
39,589
38,732
34,945
12,044
-